Webinar: LipidPALOOZA - Day 4 by National Lipid Association

National Lipid Association

Welcome to Day 4 of LipidPALOOZA!
You only need to register once to participate in all sessions taking place on September 25, 2020.

Join and re-join the live webcast as needed to accommodate your busy schedule.

Check your inbox for a registration confirmation and reminders from BigMarker.com.

Webinar

Webinar ended

About This Webinar

12:00 - 12:30pm ET
Rare Disease Spotlight: Cerebrotendinous xanthomatosis (CTX)

12:45 - 1:35pm ET
Expert Theater: An Approach to Managing Lipids: Oral, Nonstatin Therapies for Lowering LDL-C
- Hosted by Esperion Therapeutics

The session will cover the following information:
• Cardiovascular disease and its mortality and morbidity
• Unique mechanism of action for two treatment options
• Efficacy data for two treatment options
• Safety data for two treatment options
• Overview of the ongoing Outcomes trial

1:35 - 2:00pm ET
Conversation Break: Q&A on Body Composition and CAC Scoring

2:00 - 2:30pm ET
Practical & Objective Physical Activity Measures for the Busy Clinician

3:30 - 4:00pm ET
The Future of Management in Type 2 Diabetes, Hypertriglyceridemia, and Non-Alcoholic Fatty Liver Disease
- Sponsored by Pfizer

5:00 - 6:00pm ET
The FCS Diet – Recommendations and Virtual Cooking Demonstration
- Supported by Akcea Therapeutics

Presenters

Ralph La Forge, MSc

"Practical & Objective Physical Activity Measures for the Busy Clinician"

Duke University Medical Center
Durham, NC Nikon Professional Photographic Services

Pam Taub, MD

“The Future of Management in Type 2 Diabetes, Hypertriglyceridemia, and Non-Alcoholic Fatty Liver Disease”

Director of Step Family Foundation Cardiovascular Rehabilitation and Wellness Center
Associate Professor of Medicine
UC San Diego Health System
Division of Cardiovascular Medicine
La Jolla, CA

Mary Felando, MS, RDN, CLS, FNLA

"The FCS Diet – Recommendations and Virtual Cooking Demonstration"

Nutrition Consultant
Seal Beach, CA

P. Barton Duell, MD

"Rare Disease Spotlight: Cerebrotendinous xanthomatosis (CTX)”

Director, Lipid Laboratory
Director, Sterol Analysis Laboratory
Knight Cardiovascular Institute
and Division of Endocrinology, Diabetes, and Clinical Nutrition
Oregon Health/Science University
Portland, OR

James Underberg, MS, MD

"An Approach to Managing Lipids: Oral, Nonstatin Therapies for Lowering LDL-C"

Lipidology & Cardiovascular Disease Prevention
Diplomate American Board of Clinical Lipidology
Past-President National Lipid Association
President American Board of Clinical Lipidology

Melissa Goetz

“The FCS Diet – Recommendations and Virtual Cooking Demonstration”

Co President/Co Founder
FCS Foundation

Harold Edward Bays, MD

"Q&A on Body Composition and CAC Scoring"

Medical Director / President
Louisville Metabolic and Atherosclerosis Research Center
Your Body Goal
3288 Illinois Avenue
Louisville, KY

Steven Terra, PharmD

“The Future of Management in Type 2 Diabetes, Hypertriglyceridemia, and Non-Alcoholic Fatty Liver Disease”

Executive Director
Global Product Development
Pfizer Inc

Full name*

Your Email*

Do you have a question about Body Composition and CAC Scoring? Submit it here and have it answered live at the 1:35pm session.

Are you / have you ever been an NLA member?*

What is your profession?*

What is your specialty?

How did you hear about this event?